Multitude Therapeutics Inc.
Clinical trials sponsored by Multitude Therapeutics Inc., explained in plain language.
-
New drug duo aims to shrink tough lung tumors
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, AMT116 and ivosimab, in people with advanced non-small cell lung cancer that cannot be removed by surgery. The goal is to find a safe dose and see if the combo can shrink tumors. About 118 adults aged 18 to 75 will take pa…
Phase: PHASE1, PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 02:20 UTC
-
New drug combo targets advanced colorectal cancer in phase 2 trial
Disease control Not yet recruitingThis study tests a new drug called AMT-676 combined with standard chemotherapy and targeted therapy for people with advanced colorectal cancer that cannot be removed by surgery. The goal is to see if the combination is safe and effective at shrinking tumors or slowing cancer grow…
Phase: PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 02:12 UTC